BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23031678)

  • 1. Tissue biomarkers as prognostic variables of cervical cancer.
    Gadducci A; Guerrieri ME; Greco C
    Crit Rev Oncol Hematol; 2013 May; 86(2):104-29. PubMed ID: 23031678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
    Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
    Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
    Ma DM; Xu YP; Zhu L
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1519-24. PubMed ID: 21676077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
    Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
    J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva.
    Gadducci A; Tana R; Barsotti C; Guerrieri ME; Genazzani AR
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):71-83. PubMed ID: 22015047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS; Mathur SP
    Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
    Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
    Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of epidermal growth factor receptor, vascular endothelial growth factor, matrix metalloproteinase-2, and cyclooxygenase-2 in relation to human papilloma viral load and persistence of human papillomavirus after conization with negative margins.
    Song SH; Lee JK; Hur JY; Kim I; Saw HS; Park YK
    Int J Gynecol Cancer; 2006; 16(6):2009-17. PubMed ID: 17177839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
    Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of HPV DNA presence in lymph nodes as predictive factor in cervical carcinoma patients].
    Lukaszuk K; Liss J
    Wiad Lek; 2007; 60(7-8):365-70. PubMed ID: 18175557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z; Austin RM; Guo M; Zhao C
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
    Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
    Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy.
    Nagy VM; Buiga R; Brie I; Todor N; Tudoran O; Ordeanu C; Virág P; Tarta O; Rus M; Bălăcescu O
    Rom J Morphol Embryol; 2011; 52(1):53-9. PubMed ID: 21424032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.